Before the AZD5582 treatment phase of the experiment, two groups of RMs (control, n = 4; experimental [‘AZD5582’], n = 8) were balanced for sex, age at infection, CD4+ T cell frequency at ART initiation, peak viral load, and area under the curve (AUC) of pre-ART viremia (Table 1). This evidence concerns the gene CD4 and infection.